Neurohypophyseal Diabetes Insipidus
Symptoms, Doctors, Treatments, Advances & More

Save information for later
Sign Up

Learn About Neurohypophyseal Diabetes Insipidus

What is the definition of Neurohypophyseal Diabetes Insipidus?

Arginine vasopressin deficiency (previously called neurohypophyseal diabetes insipidus) is a disorder of water balance. The body normally balances fluid intake by releasing fluid in urine. However, people with arginine vasopressin deficiency produce an excessive amount of urine (polyuria), which depletes the amount of water in the body. This water loss also leads to excessive thirst (polydipsia).

What are the causes of Neurohypophyseal Diabetes Insipidus?

The familial form of arginine vasopressin deficiency is caused by variants (also called mutations) in the AVP gene. This gene provides instructions for making a hormone called arginine vasopressin (AVP), which is sometimes also called antidiuretic hormone (ADH). This hormone, which is produced and stored in the brain, helps control the body's water balance.

How prevalent is Neurohypophyseal Diabetes Insipidus?

Arginine vasopressin deficiency occurs in approximately 1 in 25,000 individuals. The acquired form is much more common than the familial form.

Is Neurohypophyseal Diabetes Insipidus an inherited disorder?

Familial arginine vasopressin deficiency is almost always inherited in an autosomal dominant pattern, which means that one copy of the altered AVP gene in each cell is sufficient to cause the disorder.

Who are the top Neurohypophyseal Diabetes Insipidus Local Doctors?
Distinguished in Neurohypophyseal Diabetes Insipidus
Endocrinology
Distinguished in Neurohypophyseal Diabetes Insipidus
Endocrinology
Referral required

Reading Hospital Endocrinology & Diabetes Center Wyomissing

1001 Reed Ave, Ste 402, 
Wyomissing, PA 
Languages Spoken:
English
Accepting New Patients

Ilan Gabriely is an Endocrinologist practicing medicine in Wyomissing, Pennsylvania. Dr. Gabriely is rated as a Distinguished provider by MediFind in the treatment of Neurohypophyseal Diabetes Insipidus. He is also highly rated in 59 other conditions, according to our data. His clinical expertise encompasses Low Blood Sugar, Hyperparathyroidism, Thyroid Cancer, and Anaplastic Thyroid Cancer. Dr. Gabriely is board certified in American Board Of Internal Medicine. Dr. Gabriely is currently accepting new patients.

Advanced in Neurohypophyseal Diabetes Insipidus
Internal Medicine
Advanced in Neurohypophyseal Diabetes Insipidus
Internal Medicine

Tower Health Medical Group Internal Medicine - Wyomissing 1st Floor

950A N Wyomissing Blvd F1, 
Wyomissing, PA 
Languages Spoken:
English, Russian
Accepting New Patients

Tatyana Erlikh is a primary care provider, practicing in Internal Medicine in Wyomissing, Pennsylvania. Dr. Erlikh is rated as an Advanced provider by MediFind in the treatment of Neurohypophyseal Diabetes Insipidus. She is also highly rated in 30 other conditions, according to our data. Her clinical expertise encompasses Psoriasis, Psoriatic Arthritis, Hypertension, and Familial Hypertension. Dr. Erlikh is board certified in American Board Of Internal Medicine. Dr. Erlikh is currently accepting new patients.

 
 
 
 
Learn about our expert tiers
Learn More
Elite in Neurohypophyseal Diabetes Insipidus
Elite in Neurohypophyseal Diabetes Insipidus
Referral may be required
Basel, BS, CH 

Mirjam Crain-Christ practices practicing medicine in Basel, Switzerland. Crain-Christ is rated as an Elite expert by MediFind in the treatment of Neurohypophyseal Diabetes Insipidus. They are also highly rated in 15 other conditions, according to our data. Their clinical expertise encompasses Diabetes Insipidus (DI), Neurohypophyseal Diabetes Insipidus, Low Sodium Level, Hormone Replacement Therapy (HRT), and Tissue Biopsy.

What are the latest Neurohypophyseal Diabetes Insipidus Clinical Trials?
Identifying a Provocation Test for Diagnosis of Oxytocin Deficiency in Youth With Hypopituitarism

Summary: An open-labeled, interventional pilot trial, 10 youth with AVP-D and 10 PD matched for age, sex, and BMI will be recruited from Pediatric Endocrinology and Neuroendocrinology at Massachusetts General Hospital and in the community. This study tests the hypothesis that oral estrogen/progestin will stimulate endogenous oxytocin release in control subjects. Eligible participants will receive two table...

Match to trials
Find the right clinical trials for you in under a minute
Get started
Effects of Intranasal Oxytocin in Patients With Arginine-vasopressin Deficiency - A Pilot Study

Summary: This is a randomized, double-blind, placebo-controlled crossover pilot study of single-dose intranasal oxytocin (6 IU and 24 IU) vs. placebo in adult men and women (aged 18 years and above) with arginine-vasopressin deficiency to evaluate the effect of oxytocin on anxiety, depression, and socioemotional functioning (Part A), with an optional randomized, double-blind, placebo-controlled 2-week repe...

Who are the sources who wrote this article ?

Published Date: July 19, 2024
Published By: National Institutes of Health